AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 139 filers reported holding AMICUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $416,000 | -23.8% | 83,733 | +13.4% | 0.00% | – |
| Q3 2016 | $546,000 | +38.9% | 73,845 | +2.5% | 0.00% | – |
| Q2 2016 | $393,000 | -33.0% | 72,024 | +3.9% | 0.00% | – |
| Q1 2016 | $587,000 | +58.6% | 69,343 | +81.6% | 0.00% | – |
| Q4 2015 | $370,000 | -32.1% | 38,177 | -2.1% | 0.00% | – |
| Q3 2015 | $545,000 | +35.9% | 38,990 | +37.6% | 0.00% | – |
| Q2 2015 | $401,000 | +111.1% | 28,334 | +61.9% | 0.00% | – |
| Q1 2015 | $190,000 | -57.8% | 17,496 | -67.7% | 0.00% | – |
| Q4 2014 | $450,000 | +448.8% | 54,115 | +290.6% | 0.00% | – |
| Q3 2014 | $82,000 | – | 13,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |